pravastatin has been researched along with Cognition Disorders in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Caunca, MR; Elfassy, T; Grasset, L; Jukema, JW; Odden, MC; Sattar, N; Smit, RAJ; Stott, DJ; Trompet, S; van Buchem, MA; van der Grond, J; Zeki Al Hazzouri, A | 1 |
| de Craen, AJ; Ford, I; Jukema, JW; Lucke, J; Mooijaart, SP; Sattar, N; Stott, DJ; Trompet, S; Westendorp, RG | 1 |
| Borba, CP; Cather, C; Cleary, SM; Copeland, PM; Fan, X; Freudenreich, O; Henderson, DC; Oppenheim, CE; Petruzzi, LJ; Stock, S; Vincenzi, B | 1 |
| Baker, R; Jackson, D | 1 |
| de Craen, AJ; Jukema, JW; le Cessie, S; Sabayan, B; Smit, RA; Trompet, S; van Buchem, MA; van der Grond, J | 1 |
| Blauw, GJ; Bollen, EL; Buckley, BM; de Craen, AJ; Ford, I; Jolles, J; Jukema, JW; Macfarlane, PW; Murphy, MB; Packard, CJ; Sattar, N; Shepherd, J; Stott, DJ; Trompet, S; van Vliet, P; Westendorp, RG | 1 |
| Blauw, GJ; Bollen, EL; de Craen, AJ; de Roos, A; Jukema, JW; Middelkoop, HA; van Buchem, MA; van der Grond, J; van Elderen, SG; Westendorp, RG | 1 |
| Blauw, GJ; Bollen, EL; Buckley, B; Cobbe, SM; Ford, I; Gaw, A; Houx, PJ; Hyland, M; Jukema, W; Kamper, AM; MacFarlane, PW; Meinders, AE; Murphy, MB; Norrie, J; Packard, CJ; Perry, IJ; Shepherd, J; Stott, DJ; Sweeney, BJ; Twomey, C; Westendorp, RG | 1 |
| Brown, EA; Gaw, A; Murray, HM | 1 |
| Admiraal-Behloul, F; Blauw, GJ; Bollen, EL; de Craen, AJ; Jolles, J; Murray, HM; Olofsen, H; ten Dam, VH; van Buchem, MA; van den Heuvel, DM; Westendorp, RG | 1 |
| Blauw, GJ; de Craen, AJ; Goekoop, R; Spilt, A; van Buchem, MA; Westendorp, RG | 1 |
| Blauw, GJ; Bollen, EL; Buckley, BM; Caslake, MJ; Cobbe, SM; Ford, I; Gaw, A; Hyland, M; Jolles, J; Jukema, JW; Kamper, AM; Macfarlane, PW; Murphy, MB; Murray, HM; Packard, CJ; Perry, IJ; Shepherd, J; Stott, DJ; Sweeney, BJ; Twomey, C; Westendorp, RG | 1 |
| Golomb, BA; Jaworski, B | 1 |
| Lanfermann, H; Meintzschel, F; Rösler, A; Sitzer, M; Steinmetz, H; Sterzer, P | 1 |
9 trial(s) available for pravastatin and Cognition Disorders
| Article | Year |
|---|---|
Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cognition; Cognition Disorders; Confounding Factors, Epidemiologic; Cross-Sectional Studies; Executive Function; Female; Follow-Up Studies; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Inflammation; Interleukin-6; Ireland; Male; Netherlands; Neuropsychological Tests; Polymorphism, Single Nucleotide; Pravastatin; Promoter Regions, Genetic; Risk Assessment; Risk Factors; Scotland; Stroke | 2013 |
A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism.
Topics: Adult; Anticholesteremic Agents; Cognition Disorders; Drug Synergism; Female; Humans; Inflammation; Lipid Metabolism; Male; Middle Aged; Pilot Projects; Pravastatin; Psychotic Disorders; Schizophrenia; Treatment Outcome | 2014 |
Higher Visit-to-Visit Low-Density Lipoprotein Cholesterol Variability Is Associated With Lower Cognitive Performance, Lower Cerebral Blood Flow, and Greater White Matter Hyperintensity Load in Older Subjects.
Topics: Aged; Attention; Cardiovascular Diseases; Cerebrovascular Circulation; Cholesterol, LDL; Cognition Disorders; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Mental Recall; Pravastatin; Prognosis; Socioeconomic Factors; White Matter | 2016 |
Pravastatin and cognitive function in the elderly. Results of the PROSPER study.
Topics: Aged; Aging; Anticholesteremic Agents; Cognition; Cognition Disorders; Female; Follow-Up Studies; Humans; Male; Neuropsychological Tests; Nootropic Agents; Pravastatin; Prospective Studies; Time Factors; Treatment Outcome | 2010 |
Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.
Topics: Aged; Aged, 80 and over; Atrophy; Brain; Cognition Disorders; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hypoglycemic Agents; Insulin; Linear Models; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Pravastatin | 2010 |
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Male; Neuropsychological Tests; Pravastatin; Prospective Studies; Reproducibility of Results | 2002 |
Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population.
Topics: Aged; Aged, 80 and over; Cerebral Infarction; Cerebral Ventricles; Cognition Disorders; Dementia, Vascular; Disease Progression; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Pravastatin; Prospective Studies; Reaction Time; Statistics as Topic | 2006 |
Not all age-related white matter hyperintensities are the same: a magnetization transfer imaging study.
Topics: Age Factors; Aged; Aged, 80 and over; Anticholesteremic Agents; Cerebral Cortex; Cerebral Ventricles; Cognition Disorders; Dementia, Vascular; Dominance, Cerebral; Double-Blind Method; Female; Frontal Lobe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Occipital Lobe; Pravastatin; Prospective Studies; Reference Values; Statistics as Topic | 2006 |
Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease.
Topics: Acetazolamide; Aged; Blood Flow Velocity; Cholesterol, LDL; Cognition Disorders; Dementia, Vascular; Epilepsy; Female; Gait Disorders, Neurologic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Linear Models; Magnetic Resonance Imaging; Male; Pilot Projects; Pravastatin; Prospective Studies; Subtraction Technique; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasomotor System | 2001 |
5 other study(ies) available for pravastatin and Cognition Disorders
| Article | Year |
|---|---|
Association of High-Density Lipoprotein Cholesterol With Cognitive Function: Findings From the PROspective Study of Pravastatin in the Elderly at Risk.
Topics: Aged; Anticholesteremic Agents; Biomarkers; Cholesterol, HDL; Cognition; Cognition Disorders; Female; Humans; Magnetic Resonance Imaging; Male; Pravastatin; Prospective Studies; Risk Factors | 2020 |
New models for describing outliers in meta-analysis.
Topics: Algorithms; Cognition Disorders; Cytidine Diphosphate Choline; Dental Caries; Fluorides; Humans; Hypercholesterolemia; Meta-Analysis as Topic; Models, Statistical; Monte Carlo Method; Paroxetine; Placebos; Pravastatin; Regression Analysis; Research Design; Software; Statistics as Topic; Toothpastes | 2016 |
Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the prospective study of pravastatin in the elderly at risk (PROSPER).
Topics: Aged; Aged, 80 and over; Aging; Anticholesteremic Agents; Cardiovascular Diseases; Cognition Disorders; Cohort Studies; Disabled Persons; Female; Humans; Lipoprotein(a); Male; Pravastatin; Predictive Value of Tests; Risk Factors | 2005 |
Association between apolipoprotein E4 and cognitive decline in elderly adults.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Anticholesteremic Agents; Apolipoprotein E4; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Dementia, Vascular; Female; Follow-Up Studies; Genetic Carrier Screening; Homozygote; Humans; Ireland; Male; Mental Status Schedule; Netherlands; Neuropsychological Tests; Phenotype; Pravastatin; Risk Factors; Scotland; Statistics as Topic; Triglycerides | 2007 |
Statins and dementia.
Topics: Anticholesteremic Agents; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Humans; Hypercholesterolemia; Lovastatin; Pravastatin; Randomized Controlled Trials as Topic; Selection Bias; Simvastatin | 2001 |